WebDisclosure WebDisclosure
Basculer en Français
9542 Companies
187922 Keywords
119853 Articles
100398 Press releases
Headlines Articles Press releases ApeX Remove
  1. Home
  2. Companies
  3. ApeX
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/02/2024 at 15:05, 1 year 7 months ago

    Apex Secures $7 Million Seed Funding to Enhance AI Platform Security

    Generative AI Cybersecurity Seed Funding AI Security Apex
  • BRIEF

    published on 05/02/2024 at 15:05, 1 year 7 months ago

    Apex obtient un financement de démarrage de 7 millions de dollars pour améliorer la sécurité de la plateforme d'IA

    Sommet IA Générative La Cyber-sécurité Financement De Démarrage Sécurité De L'IA
  • PRESS RELEASE

    published on 05/02/2024 at 15:00, 1 year 7 months ago

    Apex Emerges From Stealth With $7 Million in Seed Funding to Empower Secure AI Adoption

    Apex emerges from stealth with $7 million in seed funding to provide real-time detection, investigation, and response to cyberattacks targeting AI platforms. The security platform enables secure AI adoption within organizations while mitigating potential risks
    Generative AI Seed Funding Cyberattacks AI Security Apex
    Logo of ApeX
  • PRESS RELEASE

    published on 10/03/2023 at 15:09, 2 years 2 months ago

    ApeX Protocol Launches Telegram Bot for Effortless Decentralized Derivatives Trading

    Logo of ApeX
Accesswire
  • Published on 12/17/2025 at 09:05, 16 minutes ago

    Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies

  • Published on 12/17/2025 at 08:00, 1 hour 21 minutes ago

    Pulsar Helium Awards Security Based Compensation

  • Published on 12/16/2025 at 23:20, 10 hours 1 minute ago

    Tactical Resources Announces Shareholder Approval of Arrangement With Plum Acquisition Corp. III

  • Published on 12/16/2025 at 23:20, 10 hours 1 minute ago

    GMV Minerals Announces Upsize of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption

  • Published on 12/16/2025 at 23:07, 10 hours 14 minutes ago

    Linear Minerals Corp Closes First Tranche of Private Placement Financing

View all ACCESSWIRE
EQS Group
  • Published on 12/17/2025 at 09:05, 16 minutes ago

    Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology

  • Published on 12/17/2025 at 09:00, 21 minutes ago

    Financial Conduct Authority:

  • Published on 12/17/2025 at 09:00, 21 minutes ago

    Removal- Diversity Funding No. 1 Limited

  • Published on 12/17/2025 at 08:30, 51 minutes ago

    Neo Energy Metals plc - Restoration

  • Published on 12/17/2025 at 08:30, 51 minutes ago

    GLOBAL ESG MONITOR 2025: MATERIALITY ANALYSIS WIDELY ADOPTED – INTEGRATION INTO RISIK MANAGEMENT SHOWS GAPS

View all EQS
Les Echos
  • Published on 12/16/2025 at 21:45, 11 hours 36 minutes ago

    Mise à disposition du rapport financier annuel

  • Published on 12/16/2025 at 20:10, 13 hours 11 minutes ago

    donation of shares of Seval, member of the Feuillet family concert

  • Published on 12/16/2025 at 20:10, 13 hours 11 minutes ago

    Donation de titres de la société Seval, membre du concert familial Feuillet

  • Published on 12/16/2025 at 18:53, 14 hours 28 minutes ago

    Number of shares and voting rights - November 2025 (In French only)

  • Published on 12/16/2025 at 18:53, 14 hours 28 minutes ago

    Nombre total d'actions et droits de vote - novembre 2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy